169 related articles for article (PubMed ID: 20688353)
1. Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma.
Kim HS; Kim GY; Lim SJ; Park YK; Kim YW
Hum Pathol; 2010 Nov; 41(11):1609-16. PubMed ID: 20688353
[TBL] [Abstract][Full Text] [Related]
2. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
Wu W; Pan C; Yu H; Gong H; Wang Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
[TBL] [Abstract][Full Text] [Related]
3. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder.
Xiong L; Yang Z; Yang L; Liu J; Miao X
J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153
[TBL] [Abstract][Full Text] [Related]
4. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
da Rocha AO; Coutinho LM; Scholl JG; Leboutte LD
Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
[TBL] [Abstract][Full Text] [Related]
5. Expression of the GLUT1 glucose transporter in gallbladder carcinomas.
Kim YW; Park YK; Yoon TY; Lee SM
Hepatogastroenterology; 2002; 49(46):907-11. PubMed ID: 12143238
[TBL] [Abstract][Full Text] [Related]
6. RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer.
Oshikiri T; Hida Y; Miyamoto M; Hashida H; Katoh K; Suzuoki M; Nakakubo Y; Hiraoka K; Shinohara T; Itoh T; Kondo S; Katoh H
Br J Cancer; 2001 Dec; 85(12):1922-7. PubMed ID: 11747335
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
Liu DC; Yang ZL
Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
[TBL] [Abstract][Full Text] [Related]
8. L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma.
Choi SY; Jo YS; Huang SM; Liang ZL; Min JK; Hong HJ; Kim JM
Hum Pathol; 2011 Oct; 42(10):1476-83. PubMed ID: 21496863
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma.
Leal P; García P; Sandoval A; Letelier P; Brebi P; Ili C; Álvarez H; Tapia O; Roa JC
Arch Pathol Lab Med; 2013 Apr; 137(4):552-7. PubMed ID: 23544944
[TBL] [Abstract][Full Text] [Related]
10. Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma.
Liu DC; Yang ZL; Jiang S
Cancer Biomark; 2010-2011; 8(3):113-21. PubMed ID: 22012766
[TBL] [Abstract][Full Text] [Related]
11. Hyalinizing cholecystitis and associated carcinomas: clinicopathologic analysis of a distinctive variant of cholecystitis with porcelain-like features and accompanying diagnostically challenging carcinomas.
Patel S; Roa JC; Tapia O; Dursun N; Bagci P; Basturk O; Cakir A; Losada H; Sarmiento J; Adsay V
Am J Surg Pathol; 2011 Aug; 35(8):1104-13. PubMed ID: 21716080
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
Shu GS; Yang ZL; Liu DC
Pathol Res Pract; 2012 Jul; 208(7):392-7. PubMed ID: 22658478
[TBL] [Abstract][Full Text] [Related]
13. p27(Kip1) expression in normal epithelia, precancerous lesions, and carcinomas of the gallbladder: association with cancer progression and prognosis.
Hui AM; Li X; Shi YZ; Torzilli G; Takayama T; Makuuchi M
Hepatology; 2000 May; 31(5):1068-72. PubMed ID: 10796881
[TBL] [Abstract][Full Text] [Related]
14. Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions.
Xiong L; Deng X; Wen Y; Yang Z; Miao X
World J Surg Oncol; 2013 Mar; 11():80. PubMed ID: 23531103
[TBL] [Abstract][Full Text] [Related]
15. Surgery for carcinoma of the gallbladder.
Rückert JC; Rückert RI; Gellert K; Hecker K; Müller JM
Hepatogastroenterology; 1996; 43(9):527-33. PubMed ID: 8799389
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma.
Aramaki M; Matsumoto T; Shibata K; Himeno Y; Yada K; Hirano S; Sasaki A; Kawano K; Kitano S
Hepatogastroenterology; 2004; 51(60):1609-11. PubMed ID: 15532788
[TBL] [Abstract][Full Text] [Related]
17. Correlation between MMP1-PAR1 axis and clinical outcome of primary gallbladder carcinoma.
Du X; Wang S; Lu J; Cao Y; Song N; Yang T; Dong R; Zang L; Yang Y; Wu T; Li J
Jpn J Clin Oncol; 2011 Sep; 41(9):1086-93. PubMed ID: 21835828
[TBL] [Abstract][Full Text] [Related]
18. Gallbladder cancer: Defining the indications for primary radical resection and radical re-resection.
Foster JM; Hoshi H; Gibbs JF; Iyer R; Javle M; Chu Q; Kuvshinoff B
Ann Surg Oncol; 2007 Feb; 14(2):833-40. PubMed ID: 17103074
[TBL] [Abstract][Full Text] [Related]
19. Low p27Kip1 expression is an independent prognostic factor in gallbladder carcinoma.
Filipits M; Puhalla H; Wrba F
Anticancer Res; 2003; 23(1B):675-9. PubMed ID: 12680166
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological study of depth of subserosal invasion in patients with pT2 gallbladder carcinoma.
Sasaki R; Uesugi N; Itabashi H; Fujita T; Takeda Y; Hoshikawa K; Takahashi M; Funato O; Nitta H; Sugai T; Kanno S; Saito K
J Surg Oncol; 2005 Nov; 92(2):83-8. PubMed ID: 16231372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]